↓ Skip to main content

Improvement of Airflow Limitation by Fluticasone Propionate/Salmeterol in Chronic Obstructive Pulmonary Disease: What is the Specific Marker?

Overview of attention for article published in Frontiers in Pharmacology, January 2011
Altmetric Badge

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
34 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Improvement of Airflow Limitation by Fluticasone Propionate/Salmeterol in Chronic Obstructive Pulmonary Disease: What is the Specific Marker?
Published in
Frontiers in Pharmacology, January 2011
DOI 10.3389/fphar.2011.00036
Pubmed ID
Authors

Keiichiro Akamatsu, Kazuto Matsunaga, Hisatoshi Sugiura, Akira Koarai, Tsunahiko Hirano, Yoshiaki Minakata, Masakazu Ichinose

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 34 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 18%
Researcher 5 15%
Other 4 12%
Student > Postgraduate 4 12%
Student > Bachelor 3 9%
Other 9 26%
Unknown 3 9%
Readers by discipline Count As %
Medicine and Dentistry 22 65%
Nursing and Health Professions 2 6%
Mathematics 1 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Psychology 1 3%
Other 1 3%
Unknown 6 18%